Category: atopic dermatitis

According to a recent study, early-life antibiotic use affects the gut microbiome which may lead to an increased risk of atopic dermatitis (AD).

According to a recent study, suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.

According to a recent real-world study, dupilumab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in pediatric patients.

According to a recent study, biomarkers in the skin microbiota, antimicrobial peptides, and natural moisturizing factors may predict atopic dermatitis (AD) in infants.

According to a recent study, liquid synthetic detergents are better suited for maintaining healthy skin barrier function in patients with atopic dermatitis (AD) than soaps.

According to a recent study, the most effective atopic dermatitis (AD) treatments may also have the greatest risk of adverse events.

According to a recent study, a multidisciplinary approach using dermatologists, allergists and family members is most effective for treating difficult-to-control atopic dermatitis (AD) in children and adolescents.

The American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force has published updated atopic dermatitis (AD) guidelines based on new available treatments and evidence-based recommendations.

According to a recent study, abrocitinib is efficacious and well tolerated in atopic dermatitis (AD) patients with or without allergic comorbidities.